A 30-year-old flu vaccine still fights some modern viruses—but leaves a critical weakness exposed.
Researchers have uncovered new insights into how long flu vaccine protection can last by revisiting blood samples from people vaccinated in 1994. By examining these preserved samples, scientists found that the immune response triggered by that vaccine could still recognize and defend against some flu strains that appeared decades later. However, the protection was incomplete, leaving certain strains largely unchallenged.
Long-Term Flu Immunity From a 1994 Vaccine
The study analyzed samples from 175 individuals who received a flu shot in 1994. These samples revealed that immunity from the vaccine persisted in a meaningful way, offering protection against some influenza viruses that emerged over the following 30 years. Still, the results also highlighted clear gaps, showing that not all strains were equally covered.
Flu vaccines play a central role in preventing illness worldwide, yet scientists are still working to understand how broad and durable that protection really is. One key question is how well older vaccines defend against newer, constantly evolving versions of influenza A and B viruses.
How Early Flu Exposure Shapes Immunity
Another important factor is a concept known as “original antigenic sin.” This idea suggests that the first flu strain a person encounters can influence how their immune system responds to future infections throughout life.
To explore this, Thi Nguyen and colleagues revisited a group of 89 younger and 86 older adults who had been vaccinated in 1994. The researchers studied blood samples that had been cryopreserved for three decades, including one from a participant born during the 1918 flu pandemic.
What the Frozen Samples Revealed
Using this unique collection of samples, Nguyen et al. measured both the quantity and quality of antibodies, along with memory B cell responses. They then tested how these immune defenses performed against a range of influenza A and B strains that appeared after 1994.
The results showed strong antibody responses against later H1 influenza A strains and Yamagata influenza B strains. In contrast, there was little to no protection against H3 influenza A viruses.
A Critical Gap in Protection Against H3N2
These findings point to a significant weakness in long-term flu immunity. H3 strains, including H3N2, remain a major cause of seasonal outbreaks, yet the older vaccine offered minimal defense against them.
“Considering the recent influenza epidemic outbreak of suspected H3N2 in Japan, there is an unmet need for improved preventative measures and vaccination strategies to better protect vulnerable populations from life-threatening illness, especially H3N2,” the authors conclude.
Reference: “Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses” by Thi H. O. Nguyen, Isabelle J. H. Foo, Ruth A. Purcell, Hyon-Xhi Tan, Georgia Deliyannis, Wuji Zhang, Louise Carolan, A. Jessica Hadiprodjo, Howard H. Huang, Lilith F. Allen, Ruth R. Hagen, L. Carissa Aurelia, Hayley A. McQuilten, Louise C. Rowntree, Lukasz Kedzierski, Samuel H. Wilks, Matthew R. McKay, Gregory A. Tannock, Stephen J. Kent, Karen Laurie, Annette Fox, Steven Rockman, Lorena E. Brown, Amy W. Chung, Adam K. Wheatley and Katherine Kedzierska, 1 April 2026, Science Translational Medicine.
DOI: 10.1126/scitranslmed.aea8621
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.